Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 53 (RPL31P53)

Target
RPL31P53
Molecular classification
Other, Pseudogene, not a functional protein-coding gene or established target class
01

Overview

Ribosomal protein L31 pseudogene 53 (RPL31P53) is a processed pseudogene corresponding to the ribosomal protein L31 gene. Pseudogenes are genomic sequences similar to known genes but are generally considered non-functional due to disruptive mutations or lack of transcription/translation. RPL31P53 is not believed to encode a functional protein and has no reported biological or disease relevance. It is not considered a therapeutic target or a receptor, nor does it have established use as a biomarker or drug target. It exists as one of numerous processed pseudogenes in the human genome derived from the RPL31 gene, which encodes a structural component of the ribosomal 60S subunit; however, the pseudogene itself lacks coding activity or characterized function. Key clarifications: - RPL31P53 refers specifically to a pseudogene, not a protein-coding gene. - There are no functional studies or therapeutic implications reported for RPL31P53. - Data about ribosomal protein L31 (RPL31) do not apply to the pseudogene RPL31P53. - Any mention of biological or disease roles for ribosomal pseudogenes includes general information rather than something specific for RPL31P53

Other names
RPL31_19_1315RPL31P53
02

Biological functions

OtherNo demonstrated coding function; as a pseudogene, unlikely to have direct biological functions. Pseudogenes may occasionally regulate gene expression of their parent genes through non-coding RNA mechanisms, but no evidence is available specifically for RPL31P53
03

Disease associations

OtherNo established disease role. No data support a direct, recurring pathological function for RPL31P53. Association data for protein-coding RPL31 or other ribosomal protein pseudogenes do not extend specifically to RPL31P53

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 53 (RPL31P53).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 53 (RPL31P53).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call